Winfield Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $310K | Hold |
1,750
| – | – | 0.11% | 127 |
|
|
2021
Q4 | $299K | Hold |
1,750
| – | – | 0.1% | 131 |
|
|
2021
Q3 | $283K | Hold |
1,750
| – | – | 0.1% | 128 |
|
|
2021
Q2 | $288K | Hold |
1,750
| – | – | 0.11% | 125 |
|
|
2021
Q1 | $288K | Hold |
1,750
| – | – | 0.12% | 118 |
|
|
2020
Q4 | $275K | Hold |
1,750
| – | – | 0.12% | 112 |
|
|
2020
Q3 | $261K | Hold |
1,750
| – | – | 0.12% | 104 |
|
|
2020
Q2 | $246K | Hold |
1,750
| – | – | 0.13% | 104 |
|
|
2020
Q1 | $229K | Sell |
1,750
-825
| -32% | -$117K | 0.14% | 96 |
|
|
2019
Q4 | $376K | Sell |
2,575
-1,180
| -31% | -$160K | 0.17% | 91 |
|
|
2019
Q3 | $486K | Hold |
3,755
| – | – | 0.24% | 78 |
|
|
2019
Q2 | $523K | Hold |
3,755
| – | – | 0.27% | 75 |
|
|
2019
Q1 | $525K | Sell |
3,755
-230
| -6% | -$30.8K | 0.28% | 74 |
|
|
2018
Q4 | $514K | Sell |
3,985
-100
| -2% | -$13.9K | 0.31% | 66 |
|
|
2018
Q3 | $564K | Hold |
4,085
| – | – | 0.28% | 67 |
|
|
2018
Q2 | $496K | Sell |
4,085
-400
| -9% | -$49.9K | 0.27% | 76 |
|
|
2018
Q1 | $575K | Sell |
4,485
-440
| -9% | -$59.5K | 0.31% | 75 |
|
|
2017
Q4 | $689K | Sell |
4,925
-300
| -6% | -$41.8K | 0.35% | 68 |
|
|
2017
Q3 | $679K | Sell |
5,225
-252
| -5% | -$33.4K | 0.36% | 68 |
|
|
2017
Q2 | $724K | Hold |
5,477
| – | – | 0.4% | 62 |
|
|
2017
Q1 | $682K | Sell |
5,477
-310
| -5% | -$37K | 0.39% | 66 |
|
|
2016
Q4 | $666K | Buy |
5,787
+35
| +0.6% | +$4.04K | 0.41% | 67 |
|
|
2016
Q3 | $680K | Sell |
5,752
-200
| -3% | -$24.3K | 0.43% | 65 |
|
|
2016
Q2 | $722K | Sell |
5,952
-50
| -0.8% | -$5.68K | 0.47% | 58 |
|
|
2016
Q1 | $650K | Buy |
6,002
+240
| +4% | +$24.8K | 0.44% | 62 |
|
|
2015
Q4 | $592K | Sell |
5,762
-175
| -3% | -$17.6K | 0.4% | 65 |
|
|
2015
Q3 | $554K | Sell |
5,937
-3,341
| -36% | -$323K | 0.41% | 59 |
|
|
2015
Q2 | $904K | Sell |
9,278
-520
| -5% | -$52.1K | 0.62% | 45 |
|
|
2015
Q1 | $986K | Sell |
9,798
-808
| -8% | -$82.2K | 0.69% | 43 |
|
|
2014
Q4 | $1.11M | Buy |
10,606
+361
| +4% | +$38K | 0.82% | 38 |
|
|
2014
Q3 | $1.09M | Sell |
10,245
-107
| -1% | -$11.1K | 0.81% | 39 |
|
|
2014
Q2 | $1.08M | Buy |
10,352
+998
| +11% | +$101K | 0.79% | 43 |
|
|
2014
Q1 | $919K | Buy |
9,354
+361
| +4% | +$33.5K | 0.76% | 44 |
|
|
2013
Q4 | $824K | Buy |
+8,993
| New | +$829K | 0.68% | 49 |
|
Other funds holding JNJ
WA
Winfield Associates's JNJ Position: Q1 2022 in Review
Winfield Associates held its Johnson & Johnson (JNJ) position steady in Q1 2022 at 1,750 shares worth $310K. The position accounts for 0.11% of the portfolio, ranked #127.
Winfield Associates first reported a position in JNJ in Q4 2013 and has held it in 34 quarters since. The position peaked at $1.11M in Q4 2014. 3,676 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.
- Winfield Associates held 1,750 shares of Johnson & Johnson worth $310K as of Q1 2022.
- Winfield Associates left its Johnson & Johnson share count unchanged in Q1 2022.
- Johnson & Johnson made up 0.11% of Winfield Associates's portfolio in Q1 2022, its #127 holding.
- Winfield Associates first reported a position in Johnson & Johnson in Q4 2013 and has held it in 34 quarters since.
- Winfield Associates's Johnson & Johnson position peaked at $1.11M in Q4 2014.
- 3,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.
Based on Winfield Associates's 13F filing for Q1 2022, filed 5 Apr 2022.